TY - JOUR
T1 - The novel tellurium immunomodulator AS101 inhibits interleukin-10 production and p38 MAPK expression in atopic dermatitis
AU - Sredni-Kenigsbuch, Dvora
AU - Shohat, Michael
AU - Shohat, Batia
AU - Ben-Amitai, Dan
AU - Chan, Chi Chao
AU - David, Michael
PY - 2008/6
Y1 - 2008/6
N2 - The immunomodulator, AS101, inhibits production of IL-10, IL-4 and expression of p38 MAPK, while increasing production of IFNγ and IL-2. Together with its excellent clinical safety profile in humans, suggests a potential therapeutic use for AD.
AB - The immunomodulator, AS101, inhibits production of IL-10, IL-4 and expression of p38 MAPK, while increasing production of IFNγ and IL-2. Together with its excellent clinical safety profile in humans, suggests a potential therapeutic use for AD.
UR - https://www.scopus.com/pages/publications/42649142595
U2 - 10.1016/j.jdermsci.2007.12.007
DO - 10.1016/j.jdermsci.2007.12.007
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???
C2 - 18242062
AN - SCOPUS:42649142595
SN - 0923-1811
VL - 50
SP - 232
EP - 235
JO - Journal of Dermatological Science
JF - Journal of Dermatological Science
IS - 3
ER -